Tag: Business
RFK Jr. Considered for Health Secretary as Pharma Execs Seek Stability
Robert F. Kennedy Jr., a well-known critic of the pharmaceutical industry, has been considered for the position of Health Secretary. He has been vocal about his views on how the industry has influenced U.S....
AI Drug Development Company Recursion Cuts Jobs Post Exscientia Merger
Recursion Pharmaceuticals, a company known for its innovative use of artificial intelligence and machine learning in drug development, recently made the decision to lay off employees following a merger with Exscientia. This move comes...
Unveiling JPM Day 1: A Comprehensive Overview for Investors
Unveiling JPM Day 1: A Comprehensive Overview for InvestorsWelcome to STAT’s exclusive coverage of the much-anticipated “JPM Week” in San Francisco, where the biotech world is abuzz with groundbreaking news, insightful analysis, and juicy...
Pharmacies Sue GoodRx and PBMs for Illegal Reimbursement Fees
Three independent pharmacies recently took legal action against GoodRx, a company that offers a prescription drug discount card, as well as several pharmacy benefit managers (PBMs). These lawsuits allege that GoodRx and the PBMs...
Merck Expands Portfolio with Licensing of Chinese Cancer Drug
Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...
ACA Subsidy Boost and Antitrust Speech Impact: What You Need to Know
Good day, and thank you for allowing me to share some interesting insights with you. I'm still active on the platform previously known as Twitter, which shows that old habits die hard. It seems...
Biotech Analyst and CEO Discuss Election Results: Insights from Brian Skorney and Daphne Zohar
Biotech analyst Brian Skorney and biotech executive Daphne Zohar recently appeared on "The Readout LOUD" podcast to share their thoughts on how the outcomes of the recent election may impact the biotech industry. They...
Novartis Acquires Kate Therapeutics to Advance Muscular Dystrophy Treatment
Novartis made a significant move in the field of gene therapy by acquiring Kate Therapeutics for up to $1.1 billion. This acquisition includes not only the gene therapy startup itself but also its drug...
FDA Plans to Ban Cold Medicine, Eisai’s Alzheimer’s Drug Sales, and More: Pharmalittle Update
As we approach the end of another workweek, it's time to start thinking about weekend plans. Our schedule includes tending to the Pharmalot grounds, spending time with our beloved mascots, and catching up on...
The Main Target and Focus: The article focuses on key figures attending the J.P....
Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures making headlines and sharing insights that could shape the future...
Brian Thompson: The Rise and Fall of UnitedHealthcare’s CEO
MAPLE GROVE, Minn. - On a fateful day in New York City, the world lost Brian Thompson, the esteemed CEO of UnitedHealthcare. Thompson's journey from a small town in Iowa to the pinnacle of...
Medicare Obesity Drug Coverage and 340B Analysis: Pharmalittle Updates
Good day, everyone! We hope you are all well despite the rainy weather. Remember, each day is a gift waiting to be unwrapped. As we take a short break for the upcoming holiday, let's...
